No
Nobel Ilac
Istanbul TRFounded 19643,500 employees
Private CappharmaPrivateOncologyRespiratory
Platform: Turkish Generic
Market Cap
N/A
All Drugs
3
Clinical Trials
9
Failed / Terminated
0
FDA Approved
2
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Rimabrutinib | NOB-3582 | Phase 1 | 2 | IL-13 | MyelofibrosisAtopic Derm | ||
| NOB-8652 | NOB-8652 | Approved | 3 | MET | WMSchizophrenia | ||
| Polalemzoparlimab | NOB-2280 | Approved | 4 | GPRC5D | Hemophilia AOCD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (8)